Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000897069-05-000652
Filing Date
2005-03-15
Accepted
2005-03-15 12:56:23
Documents
3
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN ISSUER sdc944.htm 6-K 818118
2 GRAPHIC kpmg.jpg GRAPHIC 3171
3 GRAPHIC kpmg2.jpg GRAPHIC 2172
  Complete submission text file 0000897069-05-000652.txt   825241
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 514-332-32
NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-12033 | Film No.: 05680899
SIC: 2835 In Vitro & In Vivo Diagnostic Substances